n-(2-(diethylamino)ethyl)-4-iodobenzamide has been researched along with dacarbazine in 1 studies
| Studies (n-(2-(diethylamino)ethyl)-4-iodobenzamide) | Trials (n-(2-(diethylamino)ethyl)-4-iodobenzamide) | Recent Studies (post-2010) (n-(2-(diethylamino)ethyl)-4-iodobenzamide) | Studies (dacarbazine) | Trials (dacarbazine) | Recent Studies (post-2010) (dacarbazine) |
|---|---|---|---|---|---|
| 32 | 4 | 7 | 7,556 | 1,463 | 3,429 |
| Protein | Taxonomy | n-(2-(diethylamino)ethyl)-4-iodobenzamide (IC50) | dacarbazine (IC50) |
|---|---|---|---|
| Matrix metalloproteinase-9 | Homo sapiens (human) | 0.556 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauder-Wüst, U; Eisenhut, M; Eskerski, H; Haberkorn, U; Wolf, M | 1 |
1 other study(ies) available for n-(2-(diethylamino)ethyl)-4-iodobenzamide and dacarbazine
| Article | Year |
|---|---|
Alkylating benzamides with melanoma cytotoxicity: experimental chemotherapy in a mouse melanoma model.
Topics: Animals; Antineoplastic Agents, Alkylating; Benzamides; Chlorambucil; Dacarbazine; Disease Models, Animal; Humans; Injections, Intraperitoneal; Male; Maximum Tolerated Dose; Melanoma, Experimental; Mice; Mice, Inbred BALB C; Mice, Nude; Skin Neoplasms; Survival Rate; Tumor Cells, Cultured | 2006 |